Location History:
- Austin, TX (US) (2020)
- Dallas, TX (US) (2008 - 2022)
Company Filing History:
4 out of 5,463 
2 out of 18 Years Active: 2008-2022
Title: Ilya Bezprozvanny: A Pioneer in Cognitive Therapy Innovations
Introduction
Ilya Bezprozvanny, an accomplished inventor based in Dallas, TX, is renowned for his significant contributions to the field of cognitive function and Alzheimer's disease treatment. With a total of four patents to his name, Bezprozvanny has been instrumental in developing therapeutic methods aimed at improving cognitive health.
Latest Patents
Among his latest innovations is a patent that outlines a method for using pridopidine to enhance cognitive function. This groundbreaking invention details a strategy for periodically administering amounts of pridopidine or its pharmaceutically acceptable salts to improve cognitive abilities in subjects. Furthermore, it offers a treatment method for individuals afflicted with Alzheimer's disease, focusing on administering a pharmaceutical composition that includes pridopidine to achieve effective results. This dual approach positions Bezprozvanny as a key player in addressing cognitive decline and related disorders.
Career Highlights
Ilya Bezprozvanny's professional journey is marked by his affiliations with notable institutions, including the University of Texas System and Prilenia Neurotherapeutics Ltd. His work at these organizations has greatly contributed to the advancement of neurotherapeutic strategies and the exploration of innovative treatments for cognitive impairments.
Collaborations
Within his professional network, Bezprozvanny has collaborated with esteemed colleagues such as Michal Geva and Merav Bassan. Together, they have contributed to the field of neuroscience and the development of transformative therapies, demonstrating the power of teamwork in driving innovation.
Conclusion
Ilya Bezprozvanny's inventions continue to have a profound impact on cognitive therapy and Alzheimer's disease treatment. His dedication to improving cognitive function through medical innovation marks him as a pivotal figure in the field, and his ongoing work promises to enhance the lives of many individuals facing cognitive challenges.